Trial Details

COMPLETED
Basic Information
Clinical ID c821
Identifier NCT02365480
Trial Title Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: Berberine Chloride|OTHER: Laboratory Biomarker Analysis|OTHER: Placebo Administration
Participant Information
Sponsor National Cancer Institute (NCI)
City Chicago
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2016-06-16
Primary Completion Date 2018-02-16
Completion Date 2019-12-13